Basel Medical (BMGL) Common Equity (2024 - 2025)

Basel Medical's Common Equity history spans 1 years, with the latest figure at $3.8 million for Q2 2025.

  • For Q2 2025, Common Equity changed N/A year-over-year to $3.8 million; the TTM value through Jun 2025 reached $3.8 million, changed N/A, while the annual FY2025 figure was $3.8 million, N/A changed from the prior year.
  • Common Equity for Q2 2025 was $3.8 million at Basel Medical.
  • Across five years, Common Equity topped out at $3.8 million in Q2 2025 and bottomed at $3.8 million in Q2 2025.